Ads
related to: is sava a good buy stockparknationalbank.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Cassava Sciences (NASDAQ:SAVA) stock took off once again during September. Rumors about the Securities and Exchange Commission (or SEC) clearing its investigation of the scandal-tarnished biotech ...
As I discussed in my last article on Cassava Sciences (NASDAQ:SAVA), controversy continues to weigh on the performance of SAVA stock. Over the past week, shares in the clinical-stage biotech firm ...
Sometimes, it’s hard to know who or what to believe. Such is the case when it comes to the ongoing U.S. Securities and Exchange Commission (SEC) probe into Cassava Sciences (NASDAQ:SAVA). As the ...
Volatility has made a dramatic come back on Wall Street, but it is merely child’s play for Cassava Sciences (SAVA). This small-cap biotech company has recently enacted one of 2020’s most ...
These twists and turns in the ongoing story make it difficult to recommend SAVA stock with confidence now. Let’s start with the basics. Cassava Sciences is a biotechnology firm with a prima.
The stock still only trades for 18.5 times forward earnings, so it's still a good buy at these prices. However, if management continues innovating and repurchasing shares, forward earnings ...